The MTHFR C677T Polymorphism and Prostate Cancer Risk: New Findings from a Meta-analysis of 7306 Cases and 8062 Controls
(ندگان)پدیدآور
پدیدآور نامشخصنوع مدرک
Textزبان مدرک
Englishچکیده
Methylenetetrahydrofolate reductase (MTHFR) is an essential enzyme involved in folate metabolism; a singlenucleotide polymorphism (SNP) C677T has been reported to be linked with altered incidences of several diseases.We here conducted a meta-analysis of 15 published epidemiological studies with a total of 7306 cases and 8062controls to evaluate its association with prostate cancer risk with overall and subgroup analyses. No statisticalrelationship was found overall with any genetic model (TT vs. CC: OR = 0.80, 95%CI = [0.62, 1.04], P = 0.094;CT vs. CC: OR = 0.97, 95%CI = [0.84; 1.12], P = 0.667; Dominant: OR = 0.94, 95%CI = [0.82; 1.07], P = 0.343;Recessive: OR = 0.81, 95%CI = [0.64; 1.04], P = 0.104), but after the exclusion of several studies, we could observethe homozygote TT to confer less susceptibility to prostate cancer in carriers; moreover, different effects of thepolymorphism on prostate cancer risk was detected from subgroup analysis stratified by participants’ residentialregion: significant reduced prostate cancer risk was found to be associated with the polymorphism from Asianstudies (TT vs. CC: OR = 0.47, 95%CI = [0.33; 0.67], P
کلید واژگان
Meta-analysisMTHFR
Polymorphism
prostate cancer risk
Ethnic Groups
شماره نشریه
6تاریخ نشر
2012-06-011391-03-12
ناشر
West Asia Organization for Cancer Prevention (WAOCP)شاپا
1513-73682476-762X




